Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa
Authors
Keywords
-
Journal
BLOOD
Volume 117, Issue 14, Pages 3912-3920
Publisher
American Society of Hematology
Online
2011-01-21
DOI
10.1182/blood-2010-08-301523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases
- (2010) M. Bender et al. BLOOD
- Arterial thrombosis complicates myeloma?
- (2010) M. Q. Lacy BLOOD
- Upregulation of the α-secretase ADAM10 - risk or reason for hope?
- (2010) Kristina Endres et al. FEBS Journal
- Oral IIa Inhibitors
- (2010) Catherine J. Lee et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Oral Xa Inhibitors
- (2010) Erica Romualdi et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin αIIbβ3
- (2010) W.-S. CHOI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Soluble Glycoprotein VI Is Raised in the Plasma of Patients With Acute Ischemic Stroke
- (2010) Mohammad Al-Tamimi et al. STROKE
- Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
- (2010) Mike Ufer THROMBOSIS AND HAEMOSTASIS
- Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin
- (2010) Xiaosui Jiang et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)
- (2009) Boris Bigalke et al. BASIC RESEARCH IN CARDIOLOGY
- Rivaroxaban, the first oral, direct factor Xa inhibitor
- (2009) Nicholas Fassiadis EXPERT OPINION ON PHARMACOTHERAPY
- Involvement of ADAM10 in axonal outgrowth and myelination of the peripheral nerve
- (2009) Parastoo Jangouk et al. GLIA
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcγRIIa and induce GPVI ectodomain shedding
- (2009) Mohammad Al-Tamimi et al. PLATELETS
- Measuring soluble platelet glycoprotein VI in human plasma by ELISA
- (2009) Mohammad Al-Tamimi et al. PLATELETS
- Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura
- (2008) E. E. GARDINER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression
- (2008) P. OHLMANN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?
- (2008) Séverine Robert et al. PHARMACOLOGICAL RESEARCH
- Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
- (2008) Keren Borensztajn et al. TRENDS IN MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started